Title |
Hallucinations in acutely admitted patients with psychosis, and effectiveness of risperidone, olanzapine, quetiapine, and ziprasidone: a pragmatic, randomized study
|
---|---|
Published in |
BMC Psychiatry, September 2013
|
DOI | 10.1186/1471-244x-13-241 |
Pubmed ID | |
Authors |
Erik Johnsen, Igne Sinkeviciute, Else-Marie Løberg, Rune A Kroken, Kenneth Hugdahl, Hugo A Jørgensen |
Abstract |
Hallucinations are prevalent in schizophrenia and related psychotic disorders and may have severe consequences for the affected patients. Antipsychotic drug trials that specifically address the anti-hallucinatory effectiveness of the respective drugs in representative samples are rare. The aims of the present study were to investigate the rate and severity of hallucinations in acutely admitted psychotic patients at hospital admission and discharge or after 6 weeks at the latest, if not discharged earlier (discharge/6 weeks); and to compare the anti-hallucinatory effectiveness of risperidone, olanzapine, quetiapine, and ziprasidone with up to 2 years' follow-up. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 2 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 50% |
Practitioners (doctors, other healthcare professionals) | 1 | 50% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 1% |
Unknown | 69 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 12 | 17% |
Student > Ph. D. Student | 9 | 13% |
Researcher | 6 | 9% |
Other | 6 | 9% |
Student > Doctoral Student | 5 | 7% |
Other | 12 | 17% |
Unknown | 20 | 29% |
Readers by discipline | Count | As % |
---|---|---|
Psychology | 14 | 20% |
Medicine and Dentistry | 13 | 19% |
Pharmacology, Toxicology and Pharmaceutical Science | 7 | 10% |
Nursing and Health Professions | 4 | 6% |
Arts and Humanities | 2 | 3% |
Other | 5 | 7% |
Unknown | 25 | 36% |